Need Help? Call 1­-866-­796-­7386
« back to stock screener

  VRX stock: Valeant Pharmaceuticals Intl I

Current Rating
Strong Buy

Previous Rating

Strong Buy
Our Stock Ratings
double the S&P500!
Learn more.
Company Statistics
Price
$17.54
Market Cap
5.39B
Sector
Health Care
Div. Growth
-
P/E
3.9
P/B
0.95
P/S
0.64
Dividend %
-
P/CF
21.1
P/FCF
2.6
Op. Cash Flow
2.29M
FCF
6.0
Op. Margin
-0.20%
Net Margin
27.60%
ROE
50.60%
ROI
9.80%
ROA
6.00%
EPS Growth
199.20%
Current Ratio
1.1
Debt/Equity
431.40%
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Kalvista Pharmaceuticals Inc (KALV) $8.86 - - 100.9M Strong Buy
Nephros, Inc. (NEPH) $0.56 - - 23.8M Strong Buy
DENTSPLY SIRONA Inc (XRAY) $49.16 - 0.70% 11.36B Strong Buy
Depomed Inc (DEPO) $6.67 - - 415.3M Strong Buy
Digirad Corporation (DRAD) $1.45 - 14.20% 31.1M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More